Unconditional sales contract of Rua manufacturing facility

MKTUPDTE
Thu, Oct 31 2024 09:33 am

At the time of this release Rua Bioscience has not received the settlement funds from the the purchaser, Awa Ora Genesis Kaitiaki Harakeke Trust of Te Araroa, for the purchase of the Gisborne manufacturing facility.

The contract is for $1.3 mill and was due to be paid in full by 5pm yesterday, 30th October 2024.

The Board have received assurances from the Trust that they intend to complete the purchase of the property and have requetsed further time before settlement.

The Board is now considering their legal options in this situation and are also in parallel working with other credible parties on an alternate purchase plan.

The Board will update the market as soon as new information is received.


ENDS  

The person who authorised this announcement:

Paul Naske
Chief Executive Officer
[email protected]
+64 21 445154


Announcement PDF


Markets News

Rakon crashes to $10.4 million loss
Markets

Rakon crashes to $10.4 million loss

Revenue and profit slashed for the first half of 2025 financial year.

Markets

Gentrack's plan for airport business to take flight

Gentrack boss Gary Miles says its airport subsidiary is a unique global platform.

Gentrack's plan for airport business to take flight
Primary Sector

Halter proves it's a cash cow

The Deloitte Fast 50 winner's NZ unit reported chunky revenue and positive cash flow. 

Halter proves it's a cash cow